If an effective vaccine is rolled out in the euro-zone in the coming months, it would lead to stronger growth next year but slower growth in 2022. With light at the end of the tunnel, policy support may be just as generous in the short term and be more focused on fiscal than monetary policy.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.